The latest health news
The Food and Drug Administration on Friday approved a new Alzheimer’s disease treatment that moderately slows cognitive decline in people with early-stage disease. The drug, called Leqembi, was developed by …
Read More
Congressional investigators sorted through more than 500,000 pages of documents from the Food and Drug Administration and Biogen to chronicle how a controversial Alzheimer’s disease drug was approved, and how …
Read More
A generic drug used widely to treat swelling associated with hypertension and heart failure showed hints in early research that it may also prevent the devastating brain damage of Alzheimer’s …
Read More
Chastened after a decisively negative review from outside advisers, the Food and Drug Administration convened a series of internal meetings in March and April where top officials hammered out a …
Read More
Harry Johns is ready to stop talking about whether or not the Food and Drug Administration should have approved Aduhelm, the divisive new Alzheimer’s treatment that got the green light …
Read More
Most visits to the memory center where I care for individuals living with Alzheimer’s disease end in disappointment. “Are there any new treatments, Dr. Karlawish?” patients or family members hopefully …
Read More
One morning in 2012, my wife Geri looked in the mirror and failed to recognize her own face. Our neurologist diagnosed Geri, a former health care executive and nurse, with …
Read More
STAT+ subscribers will have access to all-day coverage of the Friday advisory committee meeting to discuss Biogen’s Alzheimer’s drug, with regular updates on key presentations, interesting arguments, and eventually the …
Read More